Promis­ing New An­timi­cro­bials

Note­wor­thy

Amid the tur­moil and un­cer­tainty of our times, one fact is un­de­ni­able: mi­crobes con­tinue to evolve. Their very re­silience and adapt­abil­ity have led to the cur­rent cri­sis of an­timi­cro­bial re­sis­tance as mi­crobes de­velop re­sis­tance to the an­timi­cro­bial drugs used to con­trol them. Obliv­i­ous to ge­og­ra­phy or bor­ders, the spread of re­sis­tant mi­crobes has be­come a threat to hu­man health. Fu­ture sce­nar­ios even en­vi­sion rapidly es­ca­lat­ing death tolls from our in­abil­ity to ef­fi­ciently man­age mi­cro­bial pathogens.

Tack­ling the an­timi­cro­bial re­sis­tance cri­sis re­quires mul­ti­ple ap­proaches. These range from un­der­stand­ing con­sump­tion trends and lim­it­ing use in sec­tors such as an­i­mal rear­ing, where re­sis­tance has es­ca­lated, to iden­ti­fy­ing new an­tibac­te­r­ial com­pounds.

(a) Top, gene com­po­si­tion of the lrc BGC. Bot­tom, post­trans­la­tional mod­i­fi­ca­tion of the LrcA pre­cur­sor pep­tide leads to the pro­duc­tion of LAR and its variant(s). The pro­teins B1 and B2 rec­og­nize and cleave the leader pep­tide, re­spec­tively, fol­lowed by the cy­cliza­tion by LrcC. LrcF cleaves the ter­mi­nal glycine lead­ing to the for­ma­tion of LAR‑B and LAR‑C vari­ants. It re­mains un­known how the sec­ond isopep­tide bond of LAR‑B is formed. Source

A re­cent pa­per, the re­sult of a multi­group col­lab­o­ra­tion (from Mc­Mas­ter Uni­ver­sity in Canada, Gerry Wright's group and from U. of Illi­nois at Chicago, the groups of Alexan­der Mankin, Nora Vazquez-Laslop and Yury Po­likanov), re­ports on a novel broad-spec­trum pep­tide an­tibi­otic that tar­gets the bac­te­r­ial ri­bo­some. The au­thors gen­er­ated a col­lec­tion of strains from which they pre­pared and screened ex­tracts for an­tibac­te­r­ial ac­tiv­ity against Gram-neg­a­tive strains. By aim­ing for slow-grow­ing and po­ten­tially over­looked environ­mental strains and care­fully teas­ing out ac­tiv­i­ties in the ex­tracts, they dis­cov­ered the novel pep­tide an­tibi­otic lar­i­o­cidin (LAR). This pep­tide be­longs to a group of nat­ural prod­ucts known as RiPPs that are syn­the­sized via the ri­bo­some from pep­tide-en­cod­ing genes. The pre­cur­sor pep­tide gen­er­ated is then post-trans­la­tion­ally mod­i­fied, in this case re­sult­ing in a lasso pep­tide with a char­ac­ter­is­tic 3D shape that makes these mol­e­cules highly sta­ble.

Al­though many pep­tides with an­timi­cro­bial ac­tiv­ity are known, LAR has unique prop­er­ties. It is the only RiPP known to tar­get the 30S ri­bo­so­mal sub­unit. By do­ing so, it in­hibits trans­la­tion elon­ga­tion and in­duces mis­cod­ing. This pep­tide also had broad-spec­trum anti­microbial ac­tiv­ity against both Gram-pos­i­tive and Gram-neg­a­tive bac­te­ria.

It is en­cour­ag­ing to know that new an­timi­cro­bials can still be ob­tained by tweak­ing long-tried ap­proaches based on cul­tur­ing to screen en­vi­ron­men­tal mi­crobes. Hope­fully, such dis­cov­er­ies will lead to the de­vel­op­ment of much-needed an­tibac­te­r­ial drugs.

 

("Note­wor­thy" is the new for­mat for STC's Thurs­day posts. Please read our Jan 20, 2025 post out­lin­ing this and other changes in our blog.)

 

Other Posts

  • Back from the ISS – A Snip­pet

    by Christoph — In this blog, we don't usu­ally con­sider big, mul­ti­cel­lu­lar an­i­mals, say, arthro­pods like Drosophila, ne­matodes like C. el­e­gans, or tardi­grades like Hypsi­bius du­jar­dini. We do make ex­cep­tions for the hosts of mi­cro­bial en­dosym­bionts. Why al­low the 'wa­ter bears' (tardi­grades)? With body lengths of 0.5‒1 mm, they are a bit too big to be hon­orary mi­crobes but...

  • Tri­choplax & Com­pany II.

    by Christoph — When search­ing the metagenomes ob­tained from sin­gle Tri­choplax H2 in­di­vid­u­als for 16S and 18S rRNA-spe­cific se­quences, Gru­ber-Vod­icka et al. found, next to the preva­lent Tri­choplax and Grel­lia se­quences a third se­quence at high fre­quency that matched well with known 16S rRNA se­quences from the Mari­na­mar­gulis­bac­te­ria (ZB3), a branch within the phy­lum Mar­gulis­bac­te­ria...

  • Ter­mi­nal Pro­teins: End­less Pos­si­bil­i­ties

    by Merry — Al­though it is far from unan­i­mous, the great ma­jor­ity of phages stud­ied so far pack­age their genomes for in­ter­cel­lu­lar space travel as lin­ear chro­mo­somes. Why lin­ear rather than cir­cu­lar? Pack­ag­ing con­ve­nience, for one thing. Many phages, in­clud­ing all of the tailed phages, pack­age their chro­mo­somes into pre­assem­bled icosa­he­dral pro­cap­sids through a por­tal lo­cated...

  • Ar­chaeal Nin­jas

    by Elio — We con­fess to hav­ing missed a re­port of one of the mi­cro­bial world's most un­usual struc­tures. These are pili-like fil­a­ments lo­cated on an ar­chaeon that look for all the world like strands of barbed wire with a three-pronged grap­pling hook at the end. The ar­ti­cle ap­peared in 2005 and has not had any fol­low-up that we could find.